Last reviewed · How we verify

NCT04495660: HearCog

Restauration of the Auditory and Cognitive Functions in Cochlear Implanted Deaf Children in FNIRS

Recruiting now NA Last updated 23 October 2024
What this trial tests

NA trial testing Near InfraRed Spectroscopy (fNIRS) in Deafness in 80 participants. Currently enrolling.

Timeline
29 May 2020
Primary endpoint
3 June 2026
3 June 2026

Quick facts

Lead sponsorUniversity Hospital, Toulouse
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment80
Start date29 May 2020
Primary completion3 June 2026
Estimated completion3 June 2026
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Toulouse

Who can join

Adults 10 Months to 7, any sex, with Deafness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The principal aim of this study is to evaluate the cortical developement of perceptual skills and executive functions over time, in children with cochlear implants aged 10-24 months and 3-7 years compared with normally hearing subjects (NHS). To do this, the investigator will use functional Near InfraRed Spectroscopy (fNIRS) during 4 tasks that engage the childs perceptual and cognitive skills over a period of 18 months. The performance scores obtained by each participants as well as the cortical activity will be analysed and decrypted.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Deafness

Currently open trials in the same condition.

Other University Hospital, Toulouse trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04495660.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing